M Palmqvist
Overview
Explore the profile of M Palmqvist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nopp A, Johansson S, Adedoyin J, Ankerst J, Palmqvist M, Oman H
Allergy
. 2009 Oct;
65(1):56-60.
PMID: 19796193
Background: This study reports the clinical and immunological state of patients 3 years after a 6-year period of Xolair treatment for severe allergic asthma. Methods: The patient's cat allergen sensitivity,...
2.
Nopp A, Johansson S, Ankerst J, Palmqvist M, Oman H
Allergy
. 2007 Sep;
62(10):1175-81.
PMID: 17845588
Background: Many clinical trials with omalizumab, Xolair, have been reported but the treatment period has always been short, i.e. <12 months. After withdrawal, the clinical symptoms tend to return. A...
3.
Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation
Nopp A, Johansson S, Ankerst J, Bylin G, Cardell L, Gronneberg R, et al.
Allergy
. 2006 Jan;
61(3):298-302.
PMID: 16436137
Background: Monitoring of the allergen sensitivity of a patient is most important for optimal patient care and a basic prerequisite for immunomodulating treatment. The objective of this study was to...
4.
Palmqvist M, Bruce C, Sjostrand M, Arvidsson P, Lotvall J
Allergy
. 2004 Dec;
60(1):65-70.
PMID: 15575933
Early asthmatic responses (EAR) and late asthmatic responses (LAR) to allergen are induced by the local release of a series of bronchoconstrictor mediators, including leukotrienes and histamine. Both anti-leukotrienes and...
5.
Linden A, Hansson L, Andersson A, Palmqvist M, Arvidsson P, Lofdahl C, et al.
Thorax
. 2003 Mar;
58(3):217-21.
PMID: 12612296
Background: The synthetic vasoactive intestinal peptide (VIP) analogue Ro 25-1553 is a selective VIP-PACAP type 2 (VPAC(2)) receptor agonist that causes a bronchodilatory effect in guinea pigs in vivo. The...
6.
Hellgren J, Toren K, Balder B, Palmqvist M, Lowhagen O, Karlsson G
Clin Exp Allergy
. 2002 May;
32(1):64-9.
PMID: 12002739
Objective: The objective of this study was to evaluate nasal mucosal swelling with acoustic rhinometry in subjects with asthma and in healthy controls. Methods: We examined 184 individuals with asthma...
7.
Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca G, Ward J
J Allergy Clin Immunol
. 2001 Nov;
108(5):726-31.
PMID: 11692096
Background: It has been suggested that R-albuterol produces bronchodilation that is comparable with that of racemic albuterol (RS-albuterol) on a 4:1 dose-for-dose basis but systemic side effects on a 2:1...
8.
Palmqvist M, Cui Z, Sjostrand M, Linden A, Lotvall J
Eur Respir J
. 2001 Aug;
17(5):872-80.
PMID: 11488319
Allergic asthmatic individuals are often exposed to low-doses of allergen in their everyday life. Extended exposure to allergen has lead to down-regulation of the allergic process in cell systems and...
9.
Vilsvik J, Ankerst J, Palmqvist M, Persson G, SCHAANNING J, Schwabe G, et al.
Respir Med
. 2001 Jun;
95(6):484-90.
PMID: 11421506
This study aimed to compare the duration of protection against exercise-induced bronchoconstriction (EIB) after inhalation of formoterol (Oxis) Turbuhaler with that of terbutaline Turbuhaler and placebo Turbuhaler in asthmatic patients...
10.
Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lotvall J
Pulm Pharmacol Ther
. 2001 Feb;
14(1):29-34.
PMID: 11162416
Combinations of inhaled glucocorticoids and long-acting beta2-agonists in the same inhaler device have become available in recent years. In this double-blind, randomized, placebo-controlled and crossover study we have evaluated the...